CL2008003184A1 - Compuestos derivados de arilindenopirimidinas antagonistas de receptores de adenosina a2a, composicion farmaceutica que los contiene y su uso en trastornos neurodegenerativos o motores tales como parkinson, mal de huntington, atrofia sistemica multiple, degeneracion corticobasal, alzheimer, depresion y ansiedad, entre otros. - Google Patents
Compuestos derivados de arilindenopirimidinas antagonistas de receptores de adenosina a2a, composicion farmaceutica que los contiene y su uso en trastornos neurodegenerativos o motores tales como parkinson, mal de huntington, atrofia sistemica multiple, degeneracion corticobasal, alzheimer, depresion y ansiedad, entre otros.Info
- Publication number
- CL2008003184A1 CL2008003184A1 CL2008003184A CL2008003184A CL2008003184A1 CL 2008003184 A1 CL2008003184 A1 CL 2008003184A1 CL 2008003184 A CL2008003184 A CL 2008003184A CL 2008003184 A CL2008003184 A CL 2008003184A CL 2008003184 A1 CL2008003184 A1 CL 2008003184A1
- Authority
- CL
- Chile
- Prior art keywords
- arilindenopyrimidines
- huntington
- neurodegenerative
- adenosine
- anxiety
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
- C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Psychiatry (AREA)
- Psychology (AREA)
- Hospice & Palliative Care (AREA)
- Addiction (AREA)
- Pain & Pain Management (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US98245607P | 2007-10-25 | 2007-10-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CL2008003184A1 true CL2008003184A1 (es) | 2009-10-16 |
Family
ID=40225283
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CL2008003184A CL2008003184A1 (es) | 2007-10-25 | 2008-10-24 | Compuestos derivados de arilindenopirimidinas antagonistas de receptores de adenosina a2a, composicion farmaceutica que los contiene y su uso en trastornos neurodegenerativos o motores tales como parkinson, mal de huntington, atrofia sistemica multiple, degeneracion corticobasal, alzheimer, depresion y ansiedad, entre otros. |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20090111804A1 (de) |
| EP (1) | EP2220053B1 (de) |
| JP (1) | JP2011500833A (de) |
| CN (1) | CN101835760A (de) |
| AR (1) | AR069026A1 (de) |
| AT (1) | ATE509012T1 (de) |
| AU (1) | AU2008316821A1 (de) |
| CL (1) | CL2008003184A1 (de) |
| PA (1) | PA8801401A1 (de) |
| PE (1) | PE20091345A1 (de) |
| TW (1) | TW200934496A (de) |
| UY (1) | UY31421A1 (de) |
| WO (1) | WO2009055548A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20110105540A1 (en) * | 2009-10-29 | 2011-05-05 | Jackson Paul F | 2-AMINO-9-[4-(4-METHOXY-PHENOXY)-PIPERIDIN-1-YL]-4-PHENYL-INDENO[1,2-D]PYRIMIDIN-5-ONE AND ITS USE AS A HIGHLY SELECTIVE ADENOSINE A2a RECEPTOR ANTAGONIST |
| WO2011101861A1 (en) | 2010-01-29 | 2011-08-25 | Msn Laboratories Limited | Process for preparation of dpp-iv inhibitors |
| JP2025512384A (ja) | 2022-04-13 | 2025-04-17 | ギリアード サイエンシーズ, インコーポレイテッド | Trop-2発現がんを治療するための併用療法 |
| WO2025137640A1 (en) | 2023-12-22 | 2025-06-26 | Gilead Sciences, Inc. | Azaspiro wrn inhibitors |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE19627430A1 (de) * | 1996-07-08 | 1998-01-15 | Bayer Ag | Bicyclisch kondensierte Pyridine |
| US5939432A (en) * | 1997-10-29 | 1999-08-17 | Medco Research, Inc. | Thiophenes useful for modulating the adenosine receptor |
| ATE212635T1 (de) * | 1997-12-05 | 2002-02-15 | 1,3,8-triazaspiro(4,5)decan-4-on-derivate | |
| US20040127510A1 (en) * | 2002-04-16 | 2004-07-01 | Heintzelman Geoffrey R. | Arylindenopyridines and arylindenopyrimidines and related therapeutic and prophylactic methods |
| EP1673354B1 (de) * | 2003-10-03 | 2009-04-22 | Ortho-McNeil Pharmaceutical, Inc. | Arylindenopyridin- und arylindenopyrimidinverbindungen und ihre verwendung als adenosin-a2a-rezeptor antagonisten |
-
2008
- 2008-10-22 PA PA20088801401A patent/PA8801401A1/es unknown
- 2008-10-23 CN CN200880113362A patent/CN101835760A/zh active Pending
- 2008-10-23 AT AT08841729T patent/ATE509012T1/de not_active IP Right Cessation
- 2008-10-23 WO PCT/US2008/080923 patent/WO2009055548A1/en not_active Ceased
- 2008-10-23 JP JP2010531235A patent/JP2011500833A/ja not_active Withdrawn
- 2008-10-23 US US12/256,898 patent/US20090111804A1/en not_active Abandoned
- 2008-10-23 AU AU2008316821A patent/AU2008316821A1/en not_active Abandoned
- 2008-10-23 EP EP08841729A patent/EP2220053B1/de not_active Not-in-force
- 2008-10-24 PE PE2008001825A patent/PE20091345A1/es not_active Application Discontinuation
- 2008-10-24 CL CL2008003184A patent/CL2008003184A1/es unknown
- 2008-10-24 AR ARP080104647A patent/AR069026A1/es unknown
- 2008-10-24 UY UY31421A patent/UY31421A1/es unknown
- 2008-10-24 TW TW097140753A patent/TW200934496A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2011500833A (ja) | 2011-01-06 |
| UY31421A1 (es) | 2009-04-30 |
| PE20091345A1 (es) | 2009-09-24 |
| US20090111804A1 (en) | 2009-04-30 |
| PA8801401A1 (es) | 2009-05-15 |
| AR069026A1 (es) | 2009-12-23 |
| EP2220053B1 (de) | 2011-05-11 |
| CN101835760A (zh) | 2010-09-15 |
| ATE509012T1 (de) | 2011-05-15 |
| EP2220053A1 (de) | 2010-08-25 |
| TW200934496A (en) | 2009-08-16 |
| AU2008316821A1 (en) | 2009-04-30 |
| WO2009055548A1 (en) | 2009-04-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| UY32327A (es) | Antagonistas de receptores de ácido lisofosfatídico | |
| CR9786A (es) | Compuestos de bencimidazol-tiofeno | |
| CO6321189A2 (es) | Compuestos de tiazol y oxazol de bencen-sulfonamida | |
| SV2010003662A (es) | Derivados de azetidina y ciclobutano como inhibidores de jak ref. x-19081 | |
| CL2014001752A1 (es) | Compuestos biciclicos sustituidos; composicion farmaceutica que los comprende; y uso en el tratamiento de enfermedades tales como cancer, alzheimer, sida, entre otras. | |
| NI201000055A (es) | 2' - fluoro - 2' - desoxitetrahidrouridinas como inhibidores de citidina desaminasa. | |
| HN2008000179A (es) | Compuestos triciclicos,composiciones y procedimientos | |
| CL2009000860A1 (es) | Compuestos derivados de 4-fenil-4-metil-5,6-dihidro-4h-1,3-tiazina-2-amina; composiciones farmaceuticas que los contienen; y uso de los compuestos en la preparacion de medicamentos inhibidores de bace, utiles para el tratamiento de trastornos mediados por esta enzima, tal como la enfermedad de alzheimer. | |
| CR20110100A (es) | Nuevos derivados de sulfamida sustituida | |
| ECSP099490A (es) | Métodos de fabricación y uso de compuestos y composiciones | |
| SV2006002167A (es) | Moduladores del receptor de progesterona que comprenden derivados de pirrol- oxindol y sus usos ref. am101791 | |
| CL2008000434A1 (es) | Compuestos derivados de 2-amino-oxazolinas; proceso de obtencion; composicion farmaceutica; y uso en el tratamiento de enfermedades tales como depresion, ansiedad, estres, trastorno bipolar, entre otros. | |
| CO6771417A2 (es) | Antagonistas del receptor de ácido lisofosfatidico y su uso en el tratamiento de fibrosis | |
| CL2007002971A1 (es) | Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras. | |
| UY32659A (es) | Pirazinilpirazoles | |
| CL2014000246A1 (es) | Compuestos derivados fenil-3-aza-biciclo[3.1.0]hex-3-il-metanonas, inhibidores del transportador de glicina (glyt1); composicion farmaceutica que los contiene; combinacion farmaceutica; y su uso en el tratamiento de alzheimer, alteraciones cognitivas en esquizofrenia, psicosis, trastornos psiquiatricos, entre otros | |
| BRPI0818459A2 (pt) | Composição farmacêutica adequada para uso oftálmico. | |
| CR10454A (es) | Composiciones farmaceuticas novedosas de baja dosis que comprenden nimesulida , preparacion y uso de las mismas | |
| ECSP088265A (es) | Derivados de carboxamida como antagonistas del receptor muscarínico | |
| CL2007002970A1 (es) | Compuestos derivados de aminometil-4-imidazol; procedimiento de preparacion; composicion farmaceutica que los contiene; y su uso para tratar depresion, ansiedad, trastorno bipolar, entre otras. | |
| ECSP088366A (es) | 1,2-diarilimidazoles para uso como moduladores de cb1 | |
| DK1877409T3 (da) | Substituerede pyrrolopyridiner, sammensætninger, der indeholder samme, fremgangsmåde til fremstilling deraf samt anvendelse deraf | |
| CL2013002394A1 (es) | Compuestos derivados de 6,7-dialcoxi-3-isoquinolinol sustituidos, inhibidores de la pde10a; composicion farmaceutica que los comprende; y su uso en el tratamiento de trastornos metabolicos, trastornos del snc tales como enfermedad de alzheimer, demencia, depresion y trastornos neurodegenerativos tales como esclerosis multiple, entre otros. | |
| CL2011002617A1 (es) | Compuestos derivados de arilsulfonamidas 2,5-disustituidas, moduladores del receptor ccr3; composicion farmaceutica que los comprende; y uso del compuesto o de la composicion para prevenir y/o tratar un trastorno inflamatorio o inmunoregulador tal como asma, rinitis, vih, enfermedad de alzheimer, entre otros. | |
| CL2011000832A1 (es) | Compuestos derivados de tieno[2,3-d]pirimidin-4-amina sustituidos, antagonista de los receptores de adenosina a2a; composicion farmaceutica; y su uso para tratar trastornos neurodegenerativos o motores, entre otras enfermedades. |